QCG
VIR icon

Quadrant Capital Group’s Vir Biotechnology VIR Stock Holding History

Quadrant Capital Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-182
Closed -$1.63K – 2543
2026
Q1 		$1.63K Hold
182
– – ﹤0.01% 2534
2025
Q4 		$1.1K Hold
182
– – ﹤0.01% 2589
2025
Q3 		$1.04K Buy
+182
New +$931 ﹤0.01% 2554
2025
Q1 		– Sell
-474
Closed -$3.48K – 2843
2024
Q4 		$3.48K Sell
474
-2,852
-86% -$22.5K ﹤0.01% 2389
2024
Q3 		$24.9K Sell
3,326
-776
-19% -$6.74K ﹤0.01% 1805
2024
Q2 		$36.5K Sell
4,102
-2,637
-39% -$25.3K ﹤0.01% 1561
2024
Q1 		$68.3K Buy
6,739
+3,769
+127% +$38.4K 0.01% 1208
2023
Q4 		$29.9K Buy
2,970
+2,177
+275% +$19.9K ﹤0.01% 1638
2023
Q3 		$7.43K Buy
793
+192
+32% +$2.74K ﹤0.01% 2068
2023
Q2 		$14.7K Sell
601
-1,357
-69% -$34.1K ﹤0.01% 1860
2023
Q1 		$45.6K Buy
1,958
+1,403
+253% +$35.9K ﹤0.01% 1287
2022
Q4 		$14K Sell
555
-415
-43% -$10.2K ﹤0.01% 1811
2022
Q3 		$19K Buy
970
+575
+146% +$14.6K ﹤0.01% 1589
2022
Q2 		$10K Buy
395
+324
+456% +$7.56K ﹤0.01% 1683
2022
Q1 		$2K Buy
71
+38
+115% +$1.13K ﹤0.01% 2205
2021
Q4 		$1K Sell
33
-36
-52% -$1.41K ﹤0.01% 2422
2021
Q3 		$3K Buy
69
+64
+1,280% +$2.77K ﹤0.01% 2081
2021
Q2 		$0 Buy
+5
New +$227 ﹤0.01% 2575

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Quadrant Capital Group's VIR Position: Q2 2026 in Review

Quadrant Capital Group sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 182 shares — an estimated $1.63K sold.

Quadrant Capital Group first reported a position in VIR in Q2 2021 and held it in 18 quarters. The position peaked at $68.3K in Q1 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Quadrant Capital Group reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 182 Vir Biotechnology shares in Q2 2026, an estimated $1.63K.
  • Quadrant Capital Group first reported a position in Vir Biotechnology in Q2 2021 and held it in 18 quarters.
  • Quadrant Capital Group's Vir Biotechnology position peaked at $68.3K in Q1 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.